Current location: Home > Animal Models > Oncology Models > Xenograft Tumor Models > Lymphoma Model > KARPAS-299

SIDEBAR
Xenograft Tumor Models
Model KARPAS-299
Information on Cells and Models

Cell name:

KARPAS-299


Other names for the model:

KARPAS-299、Karpas 299、KARPAS 299、Karpas299、KARPAS299、K299


Cell information:

KARPAS-299 cells are derived from human anaplastic large cell lymphoma cell line. Their growth depends on ALK kinase, so they are often used for screening ALK inhibitors. Click to viewMore information.


Model information:

Subcutaneous inoculation, the mouse strain is NOD/SCID, and matrix needs to be added during inoculation. Approximately 5 days after vaccination can be grouped, and the administration time after grouping is approximately 10 days

Quotation
******

* To view this data,Please Login Or Register access

Message
Talk to our experts?

Email: BD@truwaybio.com

Business: +86 185-0139-0702

Technology: +86 137-7300-5709

Website Usage Help: +86 188-6238-7270

Landline: +86 0512-80601059              

Design your Study now?
Frequently Asked Questions
Subscribe to newsletter
Get the latest news and exclusive offers from Truwaybio
Subscription